Filing Flows › Comparisons › MEDS vs STEK
DataMeds AI vs Stemtech: MEDS and STEK compared
DataMeds AI is the larger company: $1.8M of revenue in its latest quarter (Q2 2026) against $629K for Stemtech (Q2 2026). Stemtech is growing faster (-10% against -77% a year earlier). Stemtech is more profitable, with an operating margin of -20.0% against -412.7%.
Where the money goes: MEDS and STEK
DataMeds AI (MEDS) · Q2 2026
DataMeds AI, Q2 2026: revenue $1.8M (-77% year over year), operating margin -412.7%, net loss $18.4M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.
Stemtech (STEK) · Q2 2026
Stemtech, Q2 2026: revenue $629K (-10% year over year), operating margin -20.0%, net loss $292K, operating cash flow −$55K. The chart follows the revenue to costs, profit and cash.
| DataMeds AI (MEDS) | Stemtech (STEK) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $1.8M | $629K |
| Revenue growth, Y/Y | -77% | -10% |
| Operating margin | -412.7% | -20.0% |
| Net earnings | −$18.4M | −$292K |
| Net margin | — | -46.5% |
| Operating cash flow | −$2.9M | −$55K |
Where the revenue comes from
DataMeds AI
- Pharmacy Retail Sales: $1.6M (89%)
- Third Party Logistics Services: $123K (7%)
- Product: $67K (4%)
Questions
Which is bigger, DataMeds AI or Stemtech?
DataMeds AI is the larger company: $1.8M of revenue in its latest quarter (Q2 2026) against $629K for Stemtech (Q2 2026).
Is DataMeds AI or Stemtech growing faster?
Stemtech is growing faster (-10% against -77% a year earlier).
Which is more profitable, DataMeds AI or Stemtech?
Stemtech is more profitable, with an operating margin of -20.0% against -412.7%.
More: DataMeds AI earnings · how DataMeds AI makes money · Stemtech earnings · how Stemtech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 17, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.